Reglagene's CEO Richard Austin is attending the 2023 SNO/ASCO CNS Cancer Conference.

This step confirms the safety and pharmacological activity exhibited by a drug for commercial development and paves the way to the next step: the initiation of human clinical trials.

Reglagene is honored to announce our partnership with Tech Coast Angels.

We have an incredible opportunity to join our team for a 3 month internship.

At BIO2023, we presented our new preclinical efficacy data demonstrating Reglagene’s medicine outperforming the standard of care treatment.

We are thrilled to unveil our all-new website, marking an important milestone for Reglagene!

Reglagene CEO Richard Austin leads off the Alumni session of Venture Madness 2023.

This achievement is a testament to the hard work and dedication of our team.

Thank you to Life Science Nation for selecting us to participate in the Innovator Pitch Challenge Oncology Therapeutics Vertical.